E-viri
Recenzirano
Odprti dostop
-
Heck, Christianne N.; King‐Stephens, David; Massey, Andrew D.; Nair, Dileep R.; Jobst, Barbara C.; Barkley, Gregory L.; Salanova, Vicenta; Cole, Andrew J.; Smith, Michael C.; Gwinn, Ryder P.; Skidmore, Christopher; Van Ness, Paul C.; Bergey, Gregory K.; Park, Yong D.; Miller, Ian; Geller, Eric; Rutecki, Paul A.; Zimmerman, Richard; Spencer, David C.; Goldman, Alica; Edwards, Jonathan C.; Leiphart, James W.; Wharen, Robert E.; Fessler, James; Fountain, Nathan B.; Worrell, Gregory A.; Gross, Robert E.; Eisenschenk, Stephan; Duckrow, Robert B.; Hirsch, Lawrence J.; Bazil, Carl; O'Donovan, Cormac A.; Sun, Felice T.; Courtney, Tracy A.; Seale, Cairn G.; Morrell, Martha J.
Epilepsia (Copenhagen), March 2014, Letnik: 55, Številka: 3Journal Article
Summary Objective To demonstrate the safety and effectiveness of responsive stimulation at the seizure focus as an adjunctive therapy to reduce the frequency of seizures in adults with medically intractable partial onset seizures arising from one or two seizure foci. Methods Randomized multicenter double‐blinded controlled trial of responsive focal cortical stimulation (RNS System). Subjects with medically intractable partial onset seizures from one or two foci were implanted, and 1 month postimplant were randomized 1:1 to active or sham stimulation. After the fifth postimplant month, all subjects received responsive stimulation in an open label period (OLP) to complete 2 years of postimplant follow‐up. Results All 191 subjects were randomized. The percent change in seizures at the end of the blinded period was −37.9% in the active and −17.3% in the sham stimulation group (p = 0.012, Generalized Estimating Equations). The median percent reduction in seizures in the OLP was 44% at 1 year and 53% at 2 years, which represents a progressive and significant improvement with time (p < 0.0001). The serious adverse event rate was not different between subjects receiving active and sham stimulation. Adverse events were consistent with the known risks of an implanted medical device, seizures, and of other epilepsy treatments. There were no adverse effects on neuropsychological function or mood. Significance Responsive stimulation to the seizure focus reduced the frequency of partial‐onset seizures acutely, showed improving seizure reduction over time, was well tolerated, and was acceptably safe. The RNS System provides an additional treatment option for patients with medically intractable partial‐onset seizures.
Avtor
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|
Vir: Osebne bibliografije
in: SICRIS
To gradivo vam je dostopno v celotnem besedilu. Če kljub temu želite naročiti gradivo, kliknite gumb Nadaljuj.